Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Effects of ursolic acid on sub-lesional muscle pathology in a contusion model of spinal cord injury

Effects of ursolic acid on sub-lesional muscle pathology in a contusion model of spinal cord injury

PLoS ONE, 2018 · DOI: https://doi.org/10.1371/journal.pone.0203042 · Published: August 29, 2018

Spinal Cord InjuryPharmacologyMusculoskeletal Medicine

Simple Explanation

Spinal cord injuries often lead to muscle wasting and changes in muscle fiber types below the injury site, impacting movement and metabolism. Ursolic acid, a natural compound, has shown promise in promoting muscle growth. This study investigates its effects on muscle health after spinal cord injury in mice. The study found that ursolic acid treatment improved muscle signaling, reduced the activity of genes that break down muscle, and improved muscle mass and function in mice with spinal cord injuries.

Study Duration
4 Weeks
Participants
Adult female C57Bl/6 mice (12-weeks old, ~20g)
Evidence Level
Level 2: Experimental study using a contusion model of spinal cord injury in mice.

Key Findings

  • 1
    Ursolic acid treatment attenuates SCI induced decreases in activated forms of mTOR, and signaling intermediates PI3K, AKT, and S6K.
  • 2
    Ursolic acid reduces the upregulation of catabolic genes including FOXO1, MAFbx, MURF-1, and PSMD11 after spinal cord injury.
  • 3
    Ursolic acid improves SCI induced deficits in body and sub-lesional muscle mass, as well as functional outcomes related to muscle function, motor coordination, and strength.

Research Summary

This study investigated the effects of ursolic acid (UA) on sub-lesional muscle pathology in a mouse model of spinal cord injury (SCI). The study found that UA improves anabolic IGF-1/mTOR signaling, reduces SCI-induced upregulation of proteolytic genes, and improves physical and functional measures. The findings suggest that UA is a potential therapeutic adjunctive for physical deconditioning and motor deficits observed after SCI.

Practical Implications

Therapeutic Potential

Ursolic acid may be a potential therapeutic strategy to improve muscle-specific pathological consequences of SCI.

Rehabilitation Adjunct

UA may augment rehabilitation measures using FES and similar intervention paradigms.

Cardiometabolic Benefits

UA may attenuate secondary health complications associated with cardiometabolic disorders in SCI.

Study Limitations

  • 1
    Ursolic acid was administered dissolved in corn oil, which may have influenced metabolic outcomes.
  • 2
    The study used a short-term SCI survival model.
  • 3
    The study did not directly address secondary complications related to cardiometabolic disorders.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury